BioCryst Reports Second Quarter 2026 Financial Results

Go back to BioCryst Reports Second Quarter 2026 Financial Results
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) Delayed: 8.59 +0.07 (0.82%)
Previous Close $8.52    52 Week High $10.98 
Open $8.52    52 Week Low $1.63 
Day High $8.63    P/E N/A 
Day Low $8.40    EPS $-0.68 
Volume 3,666,726